UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000002789
Receipt number R000003380
Scientific Title Randomized phase II study of continuous gefitinib plus chemotherapy versus alternation of gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive EGFR mutations (NEJ005/TCOG0902)
Date of disclosure of the study information 2009/11/20
Last modified on 2021/08/23 14:03:39

No. Disposal Last modified on Item of update
1 Insert 2009/11/20 22:14:45
2 Update 2009/12/01 22:23:57 Recruitment status
3 Update 2011/10/28 13:43:54 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2011/10/28 13:46:24 Last follow-up date
5 Update 2012/05/21 10:02:56 Recruitment status
6 Update 2013/09/09 14:25:23 TEL
Email
Email
7 Update 2014/05/26 12:26:34 Division name
Division name
Division name
8 Update 2014/06/14 13:22:37 Anticipated trial start date
Last follow-up date
Publication of results
URL related to results and publications
9 Update 2015/05/27 11:04:52 URL related to results and publications
10 Update 2015/05/27 11:06:05 Last follow-up date
11 Update 2017/05/31 13:22:14 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Name of primary person or sponsor
Organization
Email1
12 Update 2021/08/23 13:52:22 Recruitment status
Date of IRB
13 Update 2021/08/23 14:02:34 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
Email

Last name of contact person

Last name of contact person
Zip code
Address
Email
Email
Organization1
Address1
Tel1
Email1
Organization
Organization
Address
Address
Tel
Email
14 Update 2021/08/23 14:03:39 Organization